{"protocolSection": {"identificationModule": {"nctId": "NCT01348139", "orgStudyIdInfo": {"id": "D0570C00011"}, "secondaryIdInfos": [{"id": "2011-000133-37", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "AstraZeneca", "class": "INDUSTRY"}, "briefTitle": "Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma", "officialTitle": "A Randomised, Double-blind, Double-dummy, Placebo-controlled, Multicentre, 6-way Crossover, Single-dose, Phase IIa Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 Administered Via Single Inhalation Device Compared to AZD3199 Administered Via Turbuhaler\u2122 Inhaler in Patients With Asthma"}, "statusModule": {"statusVerifiedDate": "2013-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-05"}, "primaryCompletionDateStruct": {"date": "2012-02", "type": "ACTUAL"}, "completionDateStruct": {"date": "2012-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-05-03", "studyFirstSubmitQcDate": "2011-05-04", "studyFirstPostDateStruct": {"date": "2011-05-05", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2013-01-28", "resultsFirstSubmitQcDate": "2013-01-28", "resultsFirstPostDateStruct": {"date": "2013-03-05", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2013-01-28", "lastUpdatePostDateStruct": {"date": "2013-03-05", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "AstraZeneca", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "The purpose of this study is to evaluate the pharmacokinetics and pharmacodynamics of single doses of three different dry powder inhalation formulations of AZD3199 administered via Single Inhalation Device (SID) compared to AZD3199 administered via Turbuhaler\u2122 Inhaler and compared to placebo in patients with persistent asthma."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma", "patients", "lung function"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "TRIPLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 39, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "1", "type": "EXPERIMENTAL", "description": "AZD3199 800 \u00b5g inhaled via single inhaler device (SID), single dose", "interventionNames": ["Drug: AZD3199"]}, {"label": "2", "type": "EXPERIMENTAL", "description": "AZD3199 880 \u00b5g inhaled via SID, single dose", "interventionNames": ["Drug: AZD3199"]}, {"label": "3", "type": "EXPERIMENTAL", "description": "AZD3199 1400 \u00b5g inhaled via SID, single dose", "interventionNames": ["Drug: AZD3199"]}, {"label": "4", "type": "EXPERIMENTAL", "description": "AZD3199 300 \u00b5g inhaled via Turbuhaler inhaler, single dose", "interventionNames": ["Drug: AZD3199"]}, {"label": "5", "type": "EXPERIMENTAL", "description": "AZD3199 1200 \u00b5g inhaled via Turbuhaler inhaler, single dose", "interventionNames": ["Drug: AZD3199"]}, {"label": "6", "type": "PLACEBO_COMPARATOR", "description": "Placebo inhaled via Turbuhaler inhaler and SID, single dose", "interventionNames": ["Other: AZD3199 Placebo"]}], "interventions": [{"type": "DRUG", "name": "AZD3199", "description": "Inhaled via single inhaler device (SID)", "armGroupLabels": ["1", "2", "3"]}, {"type": "DRUG", "name": "AZD3199", "description": "Inhaled via Turbuhaler inhaler", "armGroupLabels": ["4", "5"]}, {"type": "OTHER", "name": "AZD3199 Placebo", "description": "Inhaled via Turbuhaler inhaler and SID", "armGroupLabels": ["6"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Emax: Maximum Value of FEV1 for Every Treatment Visits", "description": "Peak effect (Emax) within 0-24 hours of FEV1, for treatment visits 2 to 7.", "timeFrame": "0-24 hrs"}, {"measure": "E22-26h: The Average of the FEV1 Values Between 22 and 26 h for Every Treatment Visit", "description": "Trough effect (E22-26h) will be computed from the repeated measurements collected after each single dose during 22-26 hours of FEV1 from visit 2 to 7.", "timeFrame": "22-26 hrs."}], "secondaryOutcomes": [{"measure": "tEmax: Time to Maximum Value of FEV1 for Every Treatment Visit", "description": "Time to peak effect (tEmax), within 0-24 hours of FEV1, for treatment visits 2 to 7.", "timeFrame": "0 - 24 hrs."}, {"measure": "E5min: The Value of FEV1 at 5 Min for Every Treatment Visit.", "description": "Onset of effect (E5min), observed at 5 min. FEV1 for treatment visits 2 to 7.", "timeFrame": "FEV1 at 5 min"}, {"measure": "E0-24h: The Average of the FEV1 Values Between 0 and 24 h for Every Treatment Visit", "description": "Average effect over 0-24 hours of FEV1 (E0-24h), for treatment visits 2 to 7.", "timeFrame": "0 - 24 hrs"}, {"measure": "Emax: Maximum Value of Pulse for Every Treatment Visits", "description": "Peak effect (Emax) within 0-4 hours of pulse, for treatment visits 2 to 7.", "timeFrame": "0 - 4 hrs."}, {"measure": "E0-4h: The Average of the Pulse Values Between 0 and 4 h for Every Treatment Visit", "description": "Average effect (E0-4h) of Pulse, for treatment visits 2 to 7.", "timeFrame": "0 - 4 hrs."}, {"measure": "Cmax: Maximum Plasma Concentration", "description": "Maximum plasma concentration (Cmax) for AZD3199 doses", "timeFrame": "0 - 120 hrs for first two treatment visit 2 and 3 and 0 - 48 hrs for other treatment visits."}, {"measure": "AUC: Area Under the Plasma Concentration-time Curve From Zero to Infinity (AUC),", "description": "Area under the plasma concentration-time curve from zero to infinity (AUC), for AZD3199 doses", "timeFrame": "0 - 120 hrs for first two treatment visit 2 and 3 and 0 - 48 hrs for other treatment visits."}, {"measure": "Tmax:Time to Maximum Plasma Concentration", "description": "Time to maximum plasma concentration (tmax), for AZD3199 doses", "timeFrame": "0 - 120 hrs for first two treatment visit 2 and 3 and 0 - 48 hrs for other treatment visits."}, {"measure": "t1/2 :Terminal Half-life", "description": "Terminal half-life (t1/2),for AZD3199 doses", "timeFrame": "0 - 120 hrs for first two treatment visit 2 and 3 and 0 - 48 hrs for other treatment visits."}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Provision of signed and dated written informed consent prior to any study specific procedures\n* Men or women, age \u2265 18 years. Women must be of non-childbearing potential or stable on a highly effective contraceptive method for at least 3 months prior to Visit 1 and be willing to continue on the chosen contraceptive method throughout the study.\n* Be a non-smoker or ex-smoker who has stopped smoking for \\>6 months prior to study start\n* A history of asthma for at least 6 months.\n* Body Mass Index (BMI) 19-30 kg/m2\n\nExclusion Criteria:\n\n* Significant disease or disorder which, in the opinion of the Investigator, may either put the patient at risk because of participation in the study, or influence the result of the study, or the patient's ability to participate in the study\n* History of severe allergy/hypersensitivity or ongoing allergy/hypersensitivity, as judged by the Investigator or history of hypersensitivity to \u03b22-agonists in general or to AZD3199 and/or excipients\n* Prolonged QTcF \\> 450 msec or shortened QTcF \\<340 msec\n* History of alcohol/drug abuse or excessive intake of alcohol as judged by the Investigator\n* Pregnancy or lactation", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Research Site", "city": "G\u00f6teborg", "country": "Sweden", "geoPoint": {"lat": 57.70716, "lon": 11.96679}}, {"facility": "Research Site", "city": "Lule\u00e5", "country": "Sweden", "geoPoint": {"lat": 65.58415, "lon": 22.15465}}, {"facility": "Research Site", "city": "Lund", "country": "Sweden", "geoPoint": {"lat": 55.70584, "lon": 13.19321}}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "A total of 39 patients were enrolled at 3 centres in Sweden. Of these, 26 patients were randomised to receive a treatment sequence consisting of 6 different treatments in random order. The number of patients randomised was well balanced across all the treatment periods. In total, 25 patients completed the study.", "groups": [{"id": "FG000", "title": "1400 \u03bcg / Placebo / 880 \u03bcg / 1200 \u03bcg / 800 \u03bcg / 300 \u03bcg", "description": "AZD3199 1400 \u03bcg SID followed by Placebo followed by AZD3199 880 \u03bcg SID followed by AZD3199 1200 \u03bcg Turbuhaler inhaler followed by AZD3199 800 \u03bcg SID followed by AZD3199 300 \u03bcg Turbuhaler inhaler."}, {"id": "FG001", "title": "880 \u03bcg / 1400 \u03bcg / 800 \u03bcg / Placebo / 300 \u03bcg / 1200 \u03bcg", "description": "AZD3199 880 \u03bcg SID followed by AZD3199 1400 \u03bcg SID followed by AZD3199 800 \u03bcg SID followed by Placebo followed by AZD3199 300 \u03bcg Turbuhaler inhaler followed by AZD3199 1200 \u03bcg Turbuhaler inhaler."}, {"id": "FG002", "title": "800 \u03bcg / 880 \u03bcg / 300 \u03bcg / 1400 \u03bcg / 1200 \u03bcg / Placebo", "description": "AZD3199 800 \u03bcg SID followed by AZD3199 880 \u03bcg SID followed by AZD3199 300 \u03bcg Turbuhaler inhaler followed by AZD3199 1400 \u03bcg SID followed by AZD3199 1200 \u03bcg Turbuhaler inhaler followed by Placebo."}, {"id": "FG003", "title": "300 \u03bcg / 800 \u03bcg / 1200 \u03bcg / 880 \u03bcg / Placebo / 1400 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler followed by AZD3199 800 \u03bcg SID followed by AZD3199 1200 \u03bcg Turbuhaler inhaler followed by AZD3199 880 \u03bcg SID followed by Placebo followed by AZD3199 1400 \u03bcg SID."}, {"id": "FG004", "title": "1200 \u03bcg / 300 \u03bcg / Placebo / 800 \u03bcg / 1400 \u03bcg / 880 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler followed by AZD3199 300 \u03bcg Turbuhaler inhaler followed by Placebo followed by AZD3199 800 \u03bcg SID followed by AZD3199 1400 \u03bcg SID followed by AZD3199 880 \u03bcg SID."}, {"id": "FG005", "title": "Placebo / 1200 \u03bcg / 1400 \u03bcg / 300 \u03bcg / 880 \u03bcg / 800 \u03bcg", "description": "Placebo followed by AZD3199 1200 \u03bcg Turbuhaler inhaler followed by AZD3199 1400 \u03bcg SID followed by AZD3199 300 \u03bcg Turbuhaler inhaler followed by AZD3199 880 \u03bcg SID followed by AZD3199 800 \u03bcg SID."}], "periods": [{"title": "Period 1", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}, {"title": "Period 2", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}, {"title": "Period 3", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}, {"title": "Period 4", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}, {"title": "Period 5", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}, {"title": "Period 6", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "4"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Baseline Total", "description": "Total number of patients randomised and treated in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "26"}]}], "measures": [{"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"title": "All", "categories": [{"measurements": [{"groupId": "BG000", "value": "36.5", "spread": "11.29"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "6"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "20"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "24"}]}]}, {"title": "Asian", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Emax: Maximum Value of FEV1 for Every Treatment Visits", "description": "Peak effect (Emax) within 0-24 hours of FEV1, for treatment visits 2 to 7.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters", "timeFrame": "0-24 hrs", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.788", "spread": "0.782"}, {"groupId": "OG001", "value": "3.784", "spread": "0.724"}, {"groupId": "OG002", "value": "3.756", "spread": "0.733"}, {"groupId": "OG003", "value": "3.763", "spread": "0.744"}, {"groupId": "OG004", "value": "3.847", "spread": "0.781"}, {"groupId": "OG005", "value": "3.498", "spread": "0.676"}]}]}]}, {"type": "PRIMARY", "title": "E22-26h: The Average of the FEV1 Values Between 22 and 26 h for Every Treatment Visit", "description": "Trough effect (E22-26h) will be computed from the repeated measurements collected after each single dose during 22-26 hours of FEV1 from visit 2 to 7.", "populationDescription": "PD analysis set", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters", "timeFrame": "22-26 hrs.", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.448", "spread": "0.709"}, {"groupId": "OG001", "value": "3.453", "spread": "0.739"}, {"groupId": "OG002", "value": "3.495", "spread": "0.730"}, {"groupId": "OG003", "value": "3.448", "spread": "0.732"}, {"groupId": "OG004", "value": "3.569", "spread": "0.761"}, {"groupId": "OG005", "value": "3.310", "spread": "0.723"}]}]}]}, {"type": "SECONDARY", "title": "tEmax: Time to Maximum Value of FEV1 for Every Treatment Visit", "description": "Time to peak effect (tEmax), within 0-24 hours of FEV1, for treatment visits 2 to 7.", "populationDescription": "PD analysis set", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Full Range", "unitOfMeasure": "Hours", "timeFrame": "0 - 24 hrs.", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.000", "lowerLimit": "0.50", "upperLimit": "10.00"}, {"groupId": "OG001", "value": "2.000", "lowerLimit": "0.50", "upperLimit": "22.00"}, {"groupId": "OG002", "value": "2.000", "lowerLimit": "0.25", "upperLimit": "24.00"}, {"groupId": "OG003", "value": "1.000", "lowerLimit": "0.25", "upperLimit": "22.00"}, {"groupId": "OG004", "value": "4.000", "lowerLimit": "0.25", "upperLimit": "24.00"}, {"groupId": "OG005", "value": "10.000", "lowerLimit": "0.00", "upperLimit": "24.00"}]}]}]}, {"type": "SECONDARY", "title": "E5min: The Value of FEV1 at 5 Min for Every Treatment Visit.", "description": "Onset of effect (E5min), observed at 5 min. FEV1 for treatment visits 2 to 7.", "populationDescription": "PD analysis set", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters", "timeFrame": "FEV1 at 5 min", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.406", "spread": "0.743"}, {"groupId": "OG001", "value": "3.449", "spread": "0.663"}, {"groupId": "OG002", "value": "3.496", "spread": "0.692"}, {"groupId": "OG003", "value": "3.489", "spread": "0.653"}, {"groupId": "OG004", "value": "3.486", "spread": "0.723"}, {"groupId": "OG005", "value": "3.188", "spread": "0.586"}]}]}]}, {"type": "SECONDARY", "title": "E0-24h: The Average of the FEV1 Values Between 0 and 24 h for Every Treatment Visit", "description": "Average effect over 0-24 hours of FEV1 (E0-24h), for treatment visits 2 to 7.", "populationDescription": "PD analysis set", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters", "timeFrame": "0 - 24 hrs", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.489", "spread": "0.710"}, {"groupId": "OG001", "value": "3.526", "spread": "0.737"}, {"groupId": "OG002", "value": "3.537", "spread": "0.729"}, {"groupId": "OG003", "value": "3.493", "spread": "0.707"}, {"groupId": "OG004", "value": "3.636", "spread": "0.776"}, {"groupId": "OG005", "value": "3.287", "spread": "0.671"}]}]}]}, {"type": "SECONDARY", "title": "Emax: Maximum Value of Pulse for Every Treatment Visits", "description": "Peak effect (Emax) within 0-4 hours of pulse, for treatment visits 2 to 7.", "populationDescription": "PD analysis set", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Beats/min", "timeFrame": "0 - 4 hrs.", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "66.15", "spread": "11.10"}, {"groupId": "OG001", "value": "64.36", "spread": "10.10"}, {"groupId": "OG002", "value": "64.24", "spread": "9.27"}, {"groupId": "OG003", "value": "64.84", "spread": "10.18"}, {"groupId": "OG004", "value": "66.20", "spread": "12.38"}, {"groupId": "OG005", "value": "64.12", "spread": "11.22"}]}]}]}, {"type": "SECONDARY", "title": "E0-4h: The Average of the Pulse Values Between 0 and 4 h for Every Treatment Visit", "description": "Average effect (E0-4h) of Pulse, for treatment visits 2 to 7.", "populationDescription": "PD analysis set", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Beats/min", "timeFrame": "0 - 4 hrs.", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "59.85", "spread": "9.13"}, {"groupId": "OG001", "value": "59.13", "spread": "8.83"}, {"groupId": "OG002", "value": "59.07", "spread": "8.38"}, {"groupId": "OG003", "value": "58.77", "spread": "8.66"}, {"groupId": "OG004", "value": "59.73", "spread": "9.63"}, {"groupId": "OG005", "value": "58.66", "spread": "10.40"}]}]}]}, {"type": "SECONDARY", "title": "Cmax: Maximum Plasma Concentration", "description": "Maximum plasma concentration (Cmax) for AZD3199 doses", "populationDescription": "PK analysis set", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "nmol/L", "timeFrame": "0 - 120 hrs for first two treatment visit 2 and 3 and 0 - 48 hrs for other treatment visits.", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "0"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.93846", "spread": "2.497151"}, {"groupId": "OG001", "value": "5.81240", "spread": "2.497151"}, {"groupId": "OG002", "value": "6.29560", "spread": "2.827910"}, {"groupId": "OG003", "value": "3.01836", "spread": "1.294151"}, {"groupId": "OG004", "value": "13.54120", "spread": "4.337208"}]}]}]}, {"type": "SECONDARY", "title": "AUC: Area Under the Plasma Concentration-time Curve From Zero to Infinity (AUC),", "description": "Area under the plasma concentration-time curve from zero to infinity (AUC), for AZD3199 doses", "populationDescription": "PK analysis set", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "nmol*h/L", "timeFrame": "0 - 120 hrs for first two treatment visit 2 and 3 and 0 - 48 hrs for other treatment visits.", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "0"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "21.83501", "spread": "10.43729"}, {"groupId": "OG001", "value": "20.21716", "spread": "10.19966"}, {"groupId": "OG002", "value": "22.80110", "spread": "11.71379"}, {"groupId": "OG003", "value": "10.25880", "spread": "4.886541"}, {"groupId": "OG004", "value": "37.48982", "spread": "13.11484"}]}]}]}, {"type": "SECONDARY", "title": "Tmax:Time to Maximum Plasma Concentration", "description": "Time to maximum plasma concentration (tmax), for AZD3199 doses", "populationDescription": "PK analysis set", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Full Range", "unitOfMeasure": "Hours", "timeFrame": "0 - 120 hrs for first two treatment visit 2 and 3 and 0 - 48 hrs for other treatment visits.", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "0"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.47000", "lowerLimit": "0.2300", "upperLimit": "0.6200"}, {"groupId": "OG001", "value": "0.48000", "lowerLimit": "0.2700", "upperLimit": "0.6200"}, {"groupId": "OG002", "value": "0.52000", "lowerLimit": "0.2800", "upperLimit": "1.0300"}, {"groupId": "OG003", "value": "0.52000", "lowerLimit": "0.2500", "upperLimit": "0.5800"}, {"groupId": "OG004", "value": "0.48000", "lowerLimit": "0.2700", "upperLimit": "0.5800"}]}]}]}, {"type": "SECONDARY", "title": "t1/2 :Terminal Half-life", "description": "Terminal half-life (t1/2),for AZD3199 doses", "populationDescription": "PK analysis set", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Hours", "timeFrame": "0 - 120 hrs for first two treatment visit 2 and 3 and 0 - 48 hrs for other treatment visits.", "groups": [{"id": "OG000", "title": "Arm 1 - AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID"}, {"id": "OG001", "title": "Arm 2 - AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID"}, {"id": "OG002", "title": "Arm 3 - AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID"}, {"id": "OG003", "title": "Arm 4 - AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler"}, {"id": "OG004", "title": "Arm 5 - AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler"}, {"id": "OG005", "title": "Arm 6 - Placebo", "description": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "8"}, {"groupId": "OG003", "value": "8"}, {"groupId": "OG004", "value": "9"}, {"groupId": "OG005", "value": "0"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "80.97301", "spread": "24.65131"}, {"groupId": "OG001", "value": "79.24210", "spread": "22.07879"}, {"groupId": "OG002", "value": "103.7279", "spread": "113.8432"}, {"groupId": "OG003", "value": "77.46496", "spread": "47.17895"}, {"groupId": "OG004", "value": "88.99700", "spread": "46.23237"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "AZD3199 1400 \u03bcg", "description": "AZD3199 1400 \u03bcg SID", "seriousNumAffected": 0, "seriousNumAtRisk": 26, "otherNumAffected": 9, "otherNumAtRisk": 26}, {"id": "EG001", "title": "AZD3199 880 \u03bcg", "description": "AZD3199 880 \u03bcg SID", "seriousNumAffected": 0, "seriousNumAtRisk": 25, "otherNumAffected": 9, "otherNumAtRisk": 25}, {"id": "EG002", "title": "AZD3199 800 \u03bcg", "description": "AZD3199 800 \u03bcg SID", "seriousNumAffected": 0, "seriousNumAtRisk": 25, "otherNumAffected": 7, "otherNumAtRisk": 25}, {"id": "EG003", "title": "AZD3199 300 \u03bcg", "description": "AZD3199 300 \u03bcg Turbuhaler inhaler", "seriousNumAffected": 0, "seriousNumAtRisk": 25, "otherNumAffected": 7, "otherNumAtRisk": 25}, {"id": "EG004", "title": "AZD3199 1200 \u03bcg", "description": "AZD3199 1200 \u03bcg Turbuhaler inhaler", "seriousNumAffected": 0, "seriousNumAtRisk": 25, "otherNumAffected": 14, "otherNumAtRisk": 25}, {"id": "EG005", "title": "Placebo", "description": "Placebo", "seriousNumAffected": 0, "seriousNumAtRisk": 25, "otherNumAffected": 6, "otherNumAtRisk": 25}], "otherEvents": [{"term": "VOMITING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 14.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 26}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 25}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 25}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 25}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 25}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 25}]}, {"term": "NASOPHARYNGITIS", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 26}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 25}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 25}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 25}, {"groupId": "EG004", "numAffected": 5, "numAtRisk": 25}, {"groupId": "EG005", "numAffected": 4, "numAtRisk": 25}]}, {"term": "DYSGEUSIA", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 26}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 25}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 25}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 25}, {"groupId": "EG004", "numAffected": 6, "numAtRisk": 25}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 25}]}, {"term": "HEADACHE", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 26}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 25}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 25}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 25}, {"groupId": "EG004", "numAffected": 4, "numAtRisk": 25}, {"groupId": "EG005", "numAffected": 2, "numAtRisk": 25}]}, {"term": "COUGH", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 26}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 25}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 25}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 25}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 25}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 25}]}, {"term": "THROAT IRRITATION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 26}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 25}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 25}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 25}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 25}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 25}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "LTE60", "restrictiveAgreement": true}, "pointOfContact": {"title": "Gerard Lynch", "organization": "AstraZeneca", "email": "aztrial_results_posting@astrazeneca.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000544523", "term": "AZD-3199"}], "ancestors": [{"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M224548", "name": "AZD-3199", "asFound": "Nutritional advice", "relevance": "HIGH"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}